Last reviewed · How we verify
NCT07440706: iCan3 Dumping
Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome
NA trial testing Can i3 Continuous Glucose Monitoring System in Dumping Syndrome in 60 participants. Currently enrolling.
15 October 2026
Quick facts
| Lead sponsor | Kaiser Clinic and Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 15 October 2025 |
| Primary completion | 15 October 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Can i3 Continuous Glucose Monitoring System
Conditions studied
- Dumping Syndrome — all drugs for Dumping Syndrome →
- Post-bariatric Hypoglycemia — all drugs for Post-bariatric Hypoglycemia →
Sponsor
Kaiser Clinic and Hospital
Who can join
Adults 18 to 65, any sex, with Dumping Syndrome or Post-bariatric Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient safety and quality of life. Traditional capillary glucose monitoring has limited ability to detect rapid glycemic fluctuations. This prospective randomized study aims to evaluate the efficacy and safety of the iCan i3 continuous glucose monitoring (CGM) system compared to conventional capillary glucose monitoring in detecting hypoglycemic events in post-bariatric patients with late dumping syndrome. Participants will be randomized into two groups: one using CGM and one using standard fingerstick monitoring, and followed for 60 days. Clinical outcomes, hypoglycemia frequency, symptom correlation, and quality of life will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07440706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dumping Syndrome
Currently open trials in the same condition.
- NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
Other Kaiser Clinic and Hospital trials
Trials by the same sponsor.
- NCT07487467 — Autologous SVF Therapy for Type 2 Diabetes · NA · recruiting
- NCT03102697 — Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity · completed
- NCT03493620 — Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity · NA · completed
- NCT03088332 — Evaluating the Efficacy and Results of Endoscopic Gastroplasty Performed Using Overstitch in Patients With Obesity. · NA · completed
- NCT03264027 — Carbon Dioxide Versus Air Insufflation for the Application of Argon Plasma to Reduce the Gastrojejunal Anastomosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07440706 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaiser Clinic and Hospital
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07440706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing